An IgG-like fusion protein comprising an anti-Spike S2 antibody and ACE2 exhibits potent and broad neutralization against SARS-CoV-2 and variants of concern
A bispecific fusion protein with potent broad-spectrum neutralizing activity against SARS-CoV-2 variants is developed and provides a promising strategy for next-generation coronavirus biologics.